Amedisys (Nasdaq: AMED) announced on Thursday that the company has reached agreements to divest home health and hospice care centers to affiliates of the ...

UnitedHealth Group and Amedisys have agreed to sell certain home health and hospice locations to BrightSpring Health Services and The Pennant Group to help mitigate antitrust concerns over the ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the finish line, according to new filings. In documents submitted to the ...

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

Amedisys successfully earned a temporary stay ... "If successful, this lawsuit would deprive patients, nurses, providers, and the overall healthcare system of these significant benefits ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care. Although the revenue and EPS for Amedisys (AMED) give a sense of how ...

nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. Receive News & Ratings for Amedisys ...

Amedisys has a 1 year low of $82.15 and a 1 ... as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical ...

UnitedHealth and Amedisys are heading to mediation with the Department of Justice over the DOJ’s bid to block their $3.3 billion merger over anticompetitive concerns. Late last week, Judge Susan ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.